Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: A single‐center cohort study

Coronavirus disease 2019 (COVID‐19) can lead to a massive cytokine release. The use of the anti‐interleukin‐6 receptor monoclonal antibody tocilizumab (TCZ) has been proposed in this hyperinflammatory phase, although supporting evidence is limited. We retrospectively analyzed 88 consecutive patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Med Virol
Hauptverfasser: Fernández‐Ruiz, Mario, López‐Medrano, Francisco, Pérez‐Jacoiste Asín, María Asunción, Maestro de la Calle, Guillermo, Bueno, Héctor, Caro‐Teller, José Manuel, Catalán, Mercedes, de la Calle, Cristina, García‐García, Rocío, Gómez, Carlos, Laguna‐Goya, Rocío, Lizasoáin, Manuel, Martínez‐López, Joaquín, Origüen, Julia, Pablos, José Luis, Ripoll, Mar, San Juan, Rafael, Trujillo, Hernando, Lumbreras, Carlos, Aguado, José María
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Research Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7404673/
https://ncbi.nlm.nih.gov/pubmed/32672860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26308
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge